Noema Pharma AG

Tuberous Sclerosis Complex

Clinical research in Tuberous Sclerosis Complex focuses on neurological and developmental manifestations in children, adolescents, and young adults, with attention to seizure-related disease burden and associated functional impact.

  • Anticonvulsive therapy
  • Neurological symptoms
  • Paediatric and adolescent care

The therapeutic interest in this area centers on symptom control within the broader management of a complex epilepsy-associated disorder.

Trigeminal Neuralgia

Research in trigeminal neuralgia addresses severe facial pain and its persistence over time, with emphasis on treatment options for ongoing pain relief and maintenance of effect.

  • Neuropathic pain
  • Facial pain syndromes
  • Long-term pain management

The clinical focus includes both symptom reduction and sustained control of pain in adult and adolescent patients.

Tourette Syndrome

Clinical activity in Tourette syndrome is directed toward reducing tic severity and improving the burden of motor and vocal tics in adult and adolescent populations.

  • Tic disorders
  • Neurology
  • Behavioural symptom control

This area reflects interest in treatment approaches for a chronic neurodevelopmental disorder with significant functional and social impact.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Basimglurant for Children, Adolescents, and Young Adults with Tuberous Sclerosis Complex-Related Seizures

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Spain
  • Study on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Hungary Poland Spain
  • Study on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia

    Not recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Denmark Germany Italy Poland Spain